NBC
TECH icon

Neuberger Berman Canada’s Bio-Techne TECH Stock Holding History

Neuberger Berman Canada’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-19,200
Closed -$444K – 275
2014
Q4 		$444K Buy
+19,200
New +$439K 0.07% 177

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Neuberger Berman Canada's TECH Position: Q1 2015 in Review

Neuberger Berman Canada sold out of Bio-Techne (TECH) in Q1 2015, closing a stake of 19,200 shares — an estimated $444K sold.

Neuberger Berman Canada first reported a position in TECH in Q4 2014 and held it in 1 quarter. The position peaked at $444K in Q4 2014. 252 funds tracked by Wall St. Rank hold TECH as of Q1 2015.

  • Neuberger Berman Canada reported no remaining Bio-Techne position as of Q1 2015 after selling out during the quarter.
  • Neuberger Berman Canada sold 19,200 Bio-Techne shares in Q1 2015, an estimated $444K.
  • Neuberger Berman Canada first reported a position in Bio-Techne in Q4 2014 and held it in 1 quarter.
  • Neuberger Berman Canada's Bio-Techne position peaked at $444K in Q4 2014.
  • 252 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2015.

Based on Neuberger Berman Canada's 13F filing for Q1 2015, filed 30 Apr 2015.